THURSDAY, March 4, 2021 — There’s new evidence that fast-spreading variants of the coronavirus that causes COVID-19 are more resistant to antibody treatments and vaccines. Researchers assessed variants first identified in South Africa, the United Kingdom and Brazil and found that they can evade antibodies that work well against the original version of the coronavirus… Read More »
The increasing use of apps provided by the Department of Veterans Affairs is meant to improve access to patient health and benefits information in convenient digital platforms. However, members of Congress are worried that this electronic data is vulnerable. “When a veteran downloads an app from the VA’s app store, how much personal information does… Read More »
While we have heard a lot about brexanolone, marketed by Sage Therapeutics as Zulresso, for the treatment of postpartum depression, an oral version of this novel antidepressant – SAGE 217 or zuranolone – has been finishing up its Phase 3 trials. Like brexanolone, SAGE-217 is a neuroactive steroid, an analogue of allopregnanolone which is a… Read More »
Article content continued The episode was typical of what has become a serious problem in the COVID-19 pandemic: misinterpretation of trial data, with “disastrous” results for other studies, Mills and colleagues argue in a recent medical journal commentary. Influenced by media accounts, scientific oversight boards often don’t recognize there are distinct phases to COVID-19 sickness,… Read More »